Related Experiment Videos
[Treatment of heart insufficiency in the elderly with converting enzyme inhibitors]
1Faculdade de Ciências Médicas (UNL), Hospital Pulido Valente, Lisboa.
Insights
Angiotensin-Converting Enzyme (ACE) inhibitors improve quality of life and reduce mortality in patients with Congestive Heart Failure. Captopril shows recent beneficial effects, with analysis of secondary effects in elderly patients.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Congestive Heart Failure (CHF) management
- Quality of life and mortality reduction in CHF patients
Purpose:
- Review trials on ACE inhibitors for CHF quality of life improvement
- Analyze mortality reduction trials
- Examine sudden death and ventricular arrhythmias
- Report on captopril's benefits
- Analyze secondary effects in elderly CHF patients
Summary:
- ACE inhibitors are crucial for improving quality of life and reducing mortality in Congestive Heart Failure.
- Key clinical trials evaluating ACE inhibitors' impact on CHF outcomes are reviewed and analyzed.
- The study discusses sudden death, ventricular arrhythmias, captopril's efficacy, and adverse effects in elderly patients.
Impact:
- Provides a comprehensive overview of ACE inhibitors in CHF treatment.
- Highlights the role of ACE inhibitors in managing CHF symptoms and prognosis.
- Informs clinical practice regarding the use of ACE inhibitors, particularly captopril, in elderly CHF patients.
Abstract:
The main objectives of the treatment of Congestive Heart Failure are the improvement of quality of life and the reduction of mortality. Both are accomplished by the ACE inhibitors. The most important trials on the effect of ACE inhibitors on the improvement of the quality of life are reviewed. Trials about the reduction of mortality with ACE inhibitors are analysed. The sudden death problem was considered and so the relationship of this with ventricular arrhythmias. The recent evidence of a beneficial effect of captopril was reported. At last we analyse secondary effects of these drugs on the treatment of Heart Failure in old patients.